Please use this identifier to cite or link to this item:http://hdl.handle.net/20.500.12105/15291
Title
Nutritional Supplementation to Increase Influenza Vaccine Response in Children Living With HIV: A Pilot Clinical Trial
Author(s)
Sainz, Talía | Casas Flecha, Inmaculada ISCIII | González-Esguevillas, Mónica ISCIII | Escosa-Garcia, Luis | Muñoz-Fernández, María Ángeles | Prieto, Luis | Gosalbes, María José | Jiménez-Hernández, Nuria | Ramos, José Tomas | Navarro, María Luisa | Mellado, María José | Serrano-Villar, Sergio | Calvo, Cristina
Date issued
2022-07-19
Citation
Front Pediatr. 2022 Jul 19;10:919753.
Language
Inglés
Document type
journal article
Abstract
Aims: Vaccine response is poor among children living with HIV. The gut microbiota has been identified as a potential target to improve vaccine immunogenicity, but data are scarce in the context of HIV infection. Methods: Pilot, double-blind, randomized placebo-controlled trial in which 24 HIV-infected children were randomized to receive a mixture of symbiotics, omega-3/6 fatty acids, and amino acids or placebo for 4 weeks, each in combination with ART, and were then immunized against influenza. Vaccine response and safety of the nutritional supplementation were the primary outcomes. Results: Eighteen HIV-infected children completed the follow-up period (mean age 11.5 ± 4.14 years, 61% female). The nutritional supplement was safe but did not enhance the response to the influenza vaccine. A 4-fold rise in antibody titers was obtained in only 37.5% of participants in the intervention arm vs. 40% in the placebo. No immunological or inflammatory predictors of vaccine response were identified. Conclusions: In this exploratory study, a 4-week course of symbiotics did not increase influenza vaccine immunogenicity in HIV-infected children. Larger studies are warranted to address the potential of modulating the microbiome in children living with HIV.
Subject
Description
Final results of this work have been presented at the following meetings: 36rd Annual Meeting of the European Society for Pediatric Infectious Diseases (ESPID 2018), Malmö, Sweden, 28th May-June 2nd, 2018. (Ref. ESP18-0517).
Online version
DOI
Collections